Compounds > triazoles
Page last updated: 2024-08-24

triazoles and flucytosine

triazoles has been researched along with flucytosine in 112 studies

Research

Studies (112)

TimeframeStudies, this research(%)All Research%
pre-199015 (13.39)18.7374
1990's16 (14.29)18.2507
2000's52 (46.43)29.6817
2010's28 (25.00)24.3611
2020's1 (0.89)2.80

Authors

AuthorsStudies
Bava, AJ; Negroni, R1
Hughes, CE; Terrell, CL1
Cook, RA; Galgiani, JN; McIntyre, KA1
Polak, A2
Walsh, TJ1
Pizzo, A; Walsh, TJ1
Ackerbauer, H; Meingassner, JG; Mieth, H1
Abbott, AB; Cockayne, A; Hayward, J; Odds, FC1
Abruzzo, GK; Bulmer, GS; Fromtling, RA1
van 't Wout, JW; van Furth, R1
Hermans, PE; Terrell, CL1
Abruzzo, GK; Capizzi, TP; Fromtling, RA; Giltinan, DM1
Plempel, M2
Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR1
Heins, J; Heins, S; Rumler, W1
Dismukes, WE1
Graybill, JR; Holmberg, JD; Luther, MF; Najvar, LK1
Björkholm, M1
Craig, AJ; Love, DN; Malik, R; Martin, P; Wigney, DI1
Chanock, SJ; Walsh, TJ1
Jones, RN; Messer, S; Pfaller, MA1
Hollis, RJ; Pfaller, MA; Zhang, J1
Jones, RN; Marco, F; Messer, S; Pfaller, MA1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA2
Andriole, VT1
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ1
de Pauw, BE; Kullberg, BJ1
Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B1
Chatwani, A; Nyirjesy, P; Sood, G; Weitz, MV1
Kämmerer, R; Klempien, I; Kujath, P; Muhl, E1
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ1
Barchiesi, F; Bocanegra, R; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Giacometti, A; Giannini, D; Graybill, JR; Najvar, LK; Scalise, G; Schimizzi, AM1
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A1
Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL1
Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K1
Odds, FC; Sanglard, D1
Ellepola, AN; Samaranayake, LP1
Gea-Banacloche, JC; Glasmacher, A; Groll, AH; Just-Nuebling, G; Maschmeyer, G; Walsh, TJ1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzón, A; Rodriguez-Tudela, JL2
del Palacio, A; Garau, M; Pereiro, M1
Bliss, JM; Gigliotti, F; Wellington, M1
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S1
Arechavala, A; Bianchi, MH; Helou, SH; Negroni, R; Petri, N; Robles, AM1
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Schwartz, S; Thiel, E1
Gil-Lamaignere, C; Müller, FM; Zhu, LP1
Al-Fattani, MA; Douglas, LJ1
Baldassarri, I; Barchiesi, F; Fothergill, AW; Maracci, M; Rinaldi, MG; Scalise, G; Spreghini, E1
Marr, KA1
Deresinski, S; Song, JC1
Steinbach, WJ1
Chen, R; Liao, W; Yao, Z1
Benjamin, DK; Steinbach, WJ; Zaoutis, TE1
Fohrer, C; Herbrecht, R; Letscher-Bru, V; Natarajan-Amé, S; Nivoix, Y1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C1
Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C1
Alvarado-Ramírez, E; Torres-Rodríguez, JM1
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA1
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C1
Lewis, RE1
Andes, D; Kethireddy, S1
Chen, SC; Sorrell, TC1
Diekema, DJ; Pfaller, MA; Procop, GW; Rinaldi, MG1
Khakoo, RA; Khan, FA; Slain, D1
Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW1
Andes, D; Smith, J1
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN1
Cuenca-Estrella, M; Dos Anjos Martins, M; Gomez-Lopez, A; Melhem, MC; Rodriguez-Tudela, JL; Zaragoza, O1
Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A1
Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N1
Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH1
Maesaki, S; Tarumoto, N1
Alastruey-Izquierdo, A; Araujo Ribeiro, M; Cuenca-Estrella, M; Gomez-Lopez, A; Rodriguez-Tudela, JL1
Guarro, J; Mariné, M; Pastor, FJ1
Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM1
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M1
Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R1
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S1
Amorim, CS; Briones, MR; Colombo, AL; Gonçalves, SS; Melo, AS; Nucci, M; Padovan, AC1
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A1
Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE1
Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D1
Nweze, EI; Ogbonnaya, UL1
Jullien, V1
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY1
Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V1
Allada, G; Garrett, L; Marr, K; West, S1
Hamoud, S; Hayek, T; Keidar, Z1
Kontoyiannis, DP1
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M1
Kim, HR; Lee, MK; Yu, N1
Al-Nakeeb, Z; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Sudan, A; Warn, PA1
Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F1
Su, J; Sun, W; Xu, S; Yan, D1
Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH1
Furuya, N; Mano, Y; Morishige, H; Oguri, T1
Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C1
Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H1
Andes, DR; Lepak, AJ1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA1
Bulanda, M; Jagielski, T; Skóra, M1
Delarze, E; Sanglard, D1
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W1
Canteros, CE; Córdoba, S; Davel, G; Hevia, A; Isla, G; Szusz, W; Vivot, W1
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E1
Pea, F1

Reviews

29 review(s) available for triazoles and flucytosine

ArticleYear
Antifungal agents used for deep-seated mycotic infections.
    Mayo Clinic proceedings, 1992, Volume: 67, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Thromboxane-A Synthase; Triazoles

1992
Recent advances in the treatment of systemic fungal infections.
    Methods and findings in experimental and clinical pharmacology, 1987, Volume: 9, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1987
Treatment of systemic fungal infections: recent progress and current problems.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1988
Management of cryptococcosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17 Suppl 2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Meningitis; Triazoles

1993
Chemoprophylaxis of fungal infections in neutropenic patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

    Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Neutropenia; Polyenes; Triazoles

1994
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
    Bone marrow transplantation, 1996, Volume: 18 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles

1996
Current and future therapy of invasive fungal infections.
    Current clinical topics in infectious diseases, 1998, Volume: 18

    Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Flucytosine; Humans; Liposomes; Mycoses; Triazoles

1998
Therapy of invasive fungal infections.
    The Netherlands journal of medicine, 1999, Volume: 55, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy, Combination; Flucytosine; Fungemia; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Mycoses; Neutropenia; Triazoles

1999
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
    The Lancet. Infectious diseases, 2002, Volume: 2, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Oxidoreductases; Sterol 14-Demethylase; Triazoles

2002
Oral candidal infections and antimycotics.
    Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists, 2000, Volume: 11, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles

2000
Clinical pharmacology of antifungal compounds.
    Infectious disease clinics of North America, 2003, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Design; Echinocandins; Flucytosine; Fungal Proteins; Humans; Immunocompromised Host; Molecular Structure; Mycoses; Peptides; Peptides, Cyclic; Polyenes; Triazoles

2003
Antifungal pharmacotherapy for neonatal candidiasis.
    Seminars in perinatology, 2003, Volume: 27, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
CNS-aspergillosis: are there new treatment options?
    Mycoses, 2003, Volume: 46 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Invasive Candida infections: the changing epidemiology.
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Incidence; Prevalence; Risk Factors; Triazoles; United States

2004
Hepatotoxicity of antifungal agents.
    Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:2

    Topics: Allylamine; Animals; Antifungal Agents; Chemical and Drug Induced Liver Injury; Flucytosine; Humans; Imidazoles; Polyenes; Triazoles

2005
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005
Antifungal treatment in pediatric patients.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005, Volume: 8, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles

2005
Management of systemic fungal infections: alternatives to itraconazole.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles

2005
Pharmacodynamic implications for use of antifungal agents.
    Current opinion in pharmacology, 2007, Volume: 7, Issue:5

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Microbial Sensitivity Tests; Polyenes; Triazoles

2007
CNS pharmacokinetics of antifungal agents.
    Expert opinion on drug metabolism & toxicology, 2007, Volume: 3, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Triazoles

2007
Antifungal agents.
    The Medical journal of Australia, 2007, Oct-01, Volume: 187, Issue:7

    Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2007
Candida endophthalmitis: focus on current and future antifungal treatment options.
    Pharmacotherapy, 2007, Volume: 27, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2007
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:2

    Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
[Oral antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2008
[Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2011, Volume: 18 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Child; Echinocandins; Evidence-Based Medicine; Flucytosine; Humans; Mycoses; Triazoles

2011
Invasive mycoses: strategies for effective management.
    The American journal of medicine, 2012, Volume: 125, Issue:1 Suppl

    Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Aspergillosis; Bilirubin; Biomarkers; Drug Monitoring; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Leukemia; Liver; Liver Function Tests; Male; Middle Aged; Mucormycosis; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Pneumonia; Risk Factors; Triazoles

2012
Antifungal pharmacokinetics and pharmacodynamics.
    Cold Spring Harbor perspectives in medicine, 2014, Nov-10, Volume: 5, Issue:5

    Topics: Animals; Antifungal Agents; Disease Models, Animal; Echinocandins; Flucytosine; Humans; Mice; Mycoses; Polyenes; Rabbits; Rats; Triazoles

2014
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2015, Volume: 23

    Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Tolerance; Echinocandins; Flucytosine; Fungi; Host-Pathogen Interactions; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2015
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
    Mycoses, 2020, Volume: 63, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole

2020

Other Studies

83 other study(ies) available for triazoles and flucytosine

ArticleYear
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
    European journal of epidemiology, 1992, Volume: 8, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles

1992
Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:8

    Topics: Amphotericin B; Candida; Culture Media; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Temperature; Triazoles; Yeasts

1990
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Chemotherapy, 1987, Volume: 33, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles

1987
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
    Mykosen, 1985, Volume: 28, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles

1985
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Journal of general microbiology, 1985, Volume: 131, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles

1985
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
    Mycopathologia, 1986, Volume: 94, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles

1986
Chemotherapy of the pulmonary mycoses. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1987.
    The American review of respiratory disease, 1988, Volume: 138, Issue:4

    Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Lung Diseases; Mycoses; Triazoles

1988
[Antimycotic agents in generalized fungal infections].
    Nederlands tijdschrift voor geneeskunde, 1988, May-14, Volume: 132, Issue:20

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles

1988
Antifungal agents used for deep-seated mycotic infections.
    Mayo Clinic proceedings, 1987, Volume: 62, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles

1987
Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Female; Flucytosine; Luminescent Measurements; Mice; Miconazole; Oxygen Consumption; Phagocytes; Spleen; Triazoles

1986
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
    Sabouraudia, 1984, Volume: 22, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Ketoconazole; Male; Mice; Mitosporic Fungi; Mycoses; Triazoles

1984
[Correlation of in vitro and in vivo actions of azole antimycotics].
    Mykosen, 1984, Volume: 27, Issue:1

    Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; Mice, Inbred Strains; Triazoles

1984
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Rifampin; Triazoles

1984
Antimycotic activity of BAY N 7133 in animal experiments.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:5

    Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles

1984
[Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Mykosen, 1984, Volume: 27, Issue:9

    Topics: Antifungal Agents; Candida albicans; Cytosine; Flucytosine; Imidazoles; Microbial Sensitivity Tests; Solutions; Time Factors; Triazoles

1984
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:4

    Topics: Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Mice; Mice, Inbred ICR; Triazoles

1995
Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B.
    Australian veterinary journal, 1996, Volume: 73, Issue:4

    Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Cat Diseases; Cats; Cryptococcosis; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Injections, Subcutaneous; Male; Triazoles

1996
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles

1997
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
    Diagnostic microbiology and infectious disease, 1997, Volume: 27, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles

1997
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi.
    Mycopathologia, 1998, Volume: 141, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles

1998
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

1999
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Medical mycology, 1998, Volume: 36, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2000, Volume: 26, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole

2000
Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
    Infectious diseases in obstetrics and gynecology, 2000, Volume: 8, Issue:5-6

    Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Female; Flucytosine; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Vaginal Creams, Foams, and Jellies

2000
[Invasive aspergillosis on a surgical intensive care unit].
    Mycoses, 2000, Volume: 43 Suppl 2

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2000
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Mycoses, 2000, Volume: 43 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole

2000
Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:5

    Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles

2001
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    AIDS (London, England), 2001, Nov-23, Volume: 15, Issue:17

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole

2001
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2002
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2003
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole

2003
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Feb-01, Volume: 38, Issue:3

    Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Triazoles

2004
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
    Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles

2004
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.
    Mycoses, 2004, Volume: 47, Issue:7

    Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Echinocandins; Feces; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Thiazoles; Triazoles

2004
Penetration of Candida biofilms by antifungal agents.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole

2004
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Combinations; Drug Synergism; Flucytosine; Kinetics; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2004
Management of cryptococcosis in non-HIV-related patients.
    Medical mycology, 2005, Volume: 43, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Child; Child, Preschool; China; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Retrospective Studies; Skin Diseases; Treatment Outcome; Triazoles

2005
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts

2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole

2006
Effect of antifungal treatment in a murine model of blastoschizomycosis.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2007
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole

2007
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Combined therapies in a murine model of blastoschizomycosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole

2007
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Time Factors; Triazoles; Voriconazole

2007
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Canadian journal of microbiology, 2007, Volume: 53, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2007
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole

2008
In vitro susceptibility of Cryptococcus gattii clinical isolates.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Triazoles

2008
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
    Medical mycology, 2009, Volume: 47, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2009
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
    Acta ophthalmologica, 2008, Volume: 86, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2008
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
    Medical mycology, 2009, Volume: 47, Issue:5

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole

2009
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungemia; Hospitals, University; Humans; Mycological Typing Techniques; Mycoses; Onychomycosis; Opportunistic Infections; Organ Specificity; Triazoles; Trichosporon; Urine; Vaginitis

2008
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Male; Micafungin; Mice; Mycoses; Treatment Outcome; Triazoles

2009
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 2009, Volume: 22, Issue:5

    Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole

2009
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole

2009
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
    Le infezioni in medicina, 2009, Volume: 17, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2009
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
    The new microbiologica, 2009, Volume: 32, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole

2009
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungemia; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycological Typing Techniques; Polyenes; Population Surveillance; Prevalence; Triazoles

2010
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts

2010
Identification of Paecilomyces variotii in clinical samples and settings.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:8

    Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole

2010
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2010
Oral Candida isolates among HIV-infected subjects in Nigeria.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:3

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole

2011
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
    Mycopathologia, 2011, Volume: 172, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole

2011
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
    Archives of dermatology, 2011, Volume: 147, Issue:7

    Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole

2011
74-year-old man from the pacific northwest with fever and a lung mass.
    Chest, 2011, Volume: 140, Issue:3

    Topics: Aged; Amphotericin B; Antifungal Agents; British Columbia; Bromhexine; Cryptococcosis; Cryptococcus gattii; Flucytosine; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Radiography; Triazoles

2011
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
    The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:9

    Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole

2011
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
    Le infezioni in medicina, 2012, Volume: 20, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole

2012
The first Korean case of candidemia due to Candida dubliniensis.
    Annals of laboratory medicine, 2012, Volume: 32, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2012
Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; Drug Administration Routes; Drug Resistance, Fungal; Flucytosine; Galactose; Humans; Itraconazole; Lung Diseases, Fungal; Mannans; Microbial Sensitivity Tests; Pulmonary Alveoli; Triazoles

2012
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
    The new microbiologica, 2012, Volume: 35, Issue:3

    Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole

2012
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 12

    Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Intergenic; Drug Resistance, Multiple, Fungal; Female; Flucytosine; Genetic Variation; Genotype; Hemolysin Proteins; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Urinary Tract Infections; Virulence Factors; Voriconazole

2012
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
    Annals of laboratory medicine, 2012, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole

2012
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
    The Japanese journal of antibiotics, 2012, Volume: 65, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
    The Indian journal of medical research, 2012, Volume: 136, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole

2012
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
    The Journal of antibiotics, 2013, Volume: 66, Issue:11

    Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole

2013
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Mycoses, 2015, Volume: 58, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole

2015
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole

2015
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
    Mycoses, 2016, Volume: 59, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
    Mycoses, 2018, Volume: 61, Issue:7

    Topics: Animals; Antifungal Agents; Argentina; Calmodulin; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Sequence Analysis, DNA; Soil Microbiology; Sporothrix; Sporotrichosis; Triazoles

2018
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24 Suppl 1

    Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2018
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Scientific reports, 2019, 03-07, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult

2019